StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Sigyn Therapeutics cash

Cash and short-term investments held at the end of each period.

Sigyn Therapeutics's cash was $85.57K at Sep 30, 2025. For fiscal 2024 it was $12.14K, up 3.9% from the year before. Over ten years it grew 62.4% a year on average. The highest annual figure on record is $638.82K in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2024Dec 31, 2024$12.14K+3.9%
FY2023Dec 31, 2023$11.69K+39.9%
FY2022Dec 31, 2022$8.36K-97.5%
FY2021Dec 31, 2021$340.96K+304.0%
FY2020Dec 31, 2020$84.40K+16780.4%
FY2019Dec 31, 2019$500-93.3%
FY2018Dec 31, 2018$7.50K-21.8%
FY2017Dec 31, 2017$9.59K-93.6%
FY2016Dec 31, 2016$149.61K-76.6%
FY2015Dec 31, 2015$638.82K+672346.3%
FY2014Dec 31, 2014$95–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$85.57K-48.1%
Q2 FY2025Jun 30, 2025$459-99.1%
Q1 FY2025Mar 31, 2025$12.90K-60.7%
Q4 FY2024Dec 31, 2024$12.14K+3.9%
Q3 FY2024Sep 30, 2024$164.79K+155.2%
Q2 FY2024Jun 30, 2024$53.64K+127.0%
Q1 FY2024Mar 31, 2024$32.84K-89.8%
Q4 FY2023Dec 31, 2023$11.69K+39.9%
Q3 FY2023Sep 30, 2023$64.58K+129.6%
Q2 FY2023Jun 30, 2023$23.63K+224.1%
Q1 FY2023Mar 31, 2023$322.33K+296.1%
Q4 FY2022Dec 31, 2022$8.36K-97.5%
Q3 FY2022Sep 30, 2022$28.12K-94.4%
Q2 FY2022Jun 30, 2022$7.29K-99.3%
Q1 FY2022Mar 31, 2022$81.39K+1045.1%
Q4 FY2021Dec 31, 2021$340.96K+304.0%
Q3 FY2021Sep 30, 2021$502.98K+55172.1%
Q2 FY2021Jun 30, 2021$1.06M+85452.6%
Q1 FY2021Mar 31, 2021$7.11K+1321.4%
Q4 FY2020Dec 31, 2020$84.40K+16780.4%
Q2 FY2020Jun 30, 2020$910-90.2%
Q1 FY2020Mar 31, 2020$1.24K-6.9%
Q4 FY2019Dec 31, 2019$500-93.3%
Q3 FY2019Sep 30, 2019$500-93.8%
Q2 FY2019Jun 30, 2019$9.27K-1.2%
Q1 FY2019Mar 31, 2019$1.33K-96.8%
Q4 FY2018Dec 31, 2018$7.50K-21.8%
Q3 FY2018Sep 30, 2018$8.13K-62.8%
Q2 FY2018Jun 30, 2018$9.38K-70.8%
Q1 FY2018Mar 31, 2018$41.30K+348.0%
Q4 FY2017Dec 31, 2017$9.59K-93.6%
Q3 FY2017Sep 30, 2017$21.86K-42.4%
Q2 FY2017Jun 30, 2017$32.16K-77.7%
Q1 FY2017Mar 31, 2017$9.22K-97.1%
Q4 FY2016Dec 31, 2016$149.61K-76.6%
Q3 FY2016Sep 30, 2016$37.96K–
Q2 FY2016Jun 30, 2016$144.39K–
Q1 FY2016Mar 31, 2016$317.97K–
Q4 FY2015Dec 31, 2015$638.82K–

More Sigyn Therapeutics figures

See a number that looks wrong?